Sandra Cohen

Title: The Innovative Contributions of Sandra Cohen

Introduction

Sandra Cohen is a prominent inventor based in Montréal, Canada. She has made significant strides in the field of immunology, particularly in the expansion of dendritic and natural killer cells. Her work aims to enhance immune responses in patients, thereby improving outcomes in various medical scenarios.

Latest Patents

Sandra Cohen holds a patent for the "Expansion of NK and DC cells in vivo mediating immune response." This patent describes a method for expanding dendritic (DC) cells and/or natural killer (NK) cells in vivo within a patient. The process involves producing a graft of stem and progenitor cells that are cultured with UM171 or its analogues. These cells are expanded before being administered to the patient. The increase in the population of DC and NK cells leads to a heightened immune response, which can reduce transplant-related mortality, severe graft-versus-host disease, relapse, and severe viral infections.

Career Highlights

Cohen's career is marked by her dedication to advancing medical science through innovative research. She is affiliated with the Université de Montréal, where she continues to explore the potential of immune cell expansion in clinical applications. Her work has garnered attention for its potential to transform patient care in transplant medicine.

Collaborations

Sandra Cohen collaborates with esteemed colleagues such as Guy Sauvageau and Jean Roy. Their combined expertise contributes to the advancement of research in immunology and cell therapy.

Conclusion

Sandra Cohen's contributions to the field of immunology through her innovative patent and collaborative efforts highlight her role as a leading inventor. Her work promises to enhance patient outcomes and advance medical science significantly.